Adverum Biotechnologies I... (ADVM)
NASDAQ: ADVM
· Real-Time Price · USD
2.82
0.05 (1.81%)
At close: Aug 15, 2025, 3:59 PM
2.81
-0.35%
After-hours: Aug 15, 2025, 06:04 PM EDT
Adverum Biotechnologies Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -49.19M | -47.02M | -60.53M | -27.13M | -18.48M | -24.79M | -23.71M | -32.88M | -31.51M | -29.06M | -32.74M | -40.13M | -43.76M | -37.91M | -34.41M | -38.36M | -44.33M | -28.44M |
Depreciation & Amortization | 535K | 683K | 810K | 890K | 956K | 997K | 1.01M | 1.51M | 1.53M | 1.59M | 1.71M | 1.79M | 1.6M | 1.43M | 1.32M | 962K | 1.2M | 1.17M |
Stock-Based Compensation | 2.42M | 2.78M | 3.27M | 2.96M | 3.94M | 4.17M | 4.15M | 4.39M | 4.47M | 4.56M | 5.25M | 4.5M | 4.94M | 5.38M | 4.41M | 5.33M | 8.23M | 7.22M |
Other Working Capital | 4.61M | -3K | 9.38M | 1.82M | 1.75M | -2.15M | -3.37M | -3.31M | -636K | -628K | 6.27M | 7.78M | 2.95M | 616K | 3.29M | 4.58M | 116K | -2.31M |
Other Non-Cash Items | -24K | 572K | 19.26M | 42K | -8.25M | -1.12M | 7.3M | 5.58M | 5.18M | 486K | -360K | -1.99M | 1.12M | 120K | 107K | -51K | -39K | -42K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -6.47M | -75K | -715K | n/a | n/a | n/a | n/a | n/a | 488K | 1.95M | 543K | 855K |
Change in Working Capital | 7.49M | 215K | 8.93M | 2.11M | 1.98M | -2.5M | -3.68M | -2.43M | -2.21M | 3K | 7.66M | 4.02M | 5.05M | 2.05M | 2.27M | 4.38M | 485K | -3.07M |
Operating Cash Flow | -38.77M | -42.77M | -28.25M | -21.12M | -19.84M | -23.25M | -21.4M | -23.91M | -23.25M | -22.41M | -18.48M | -31.81M | -28.88M | -28.93M | -25.82M | -25.8M | -33.91M | -22.3M |
Capital Expenditures | -120K | -220K | -61K | -221K | -16K | -90K | -192K | -495K | -36K | -85K | -185K | -824K | -6.43M | -4.37M | -4.35M | -5.72M | -3.65M | -1.4M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.98M | n/a | -19.13M | -33.33M | -22.51M | -26.94M | -16.49M | n/a | n/a | -20.23M | -22.58M | -24.11M | -27.92M | -29.75M | -79.24M | -128.32M | -117.29M | -82.67M |
Sales Maturities Of Investments | 34M | 31.5M | 15M | 20.2M | 20.2M | 5M | 6.8M | 18.69M | 67.06M | 41.85M | 25M | 49.3M | 65.09M | 118.51M | 107.47M | 144.5M | 158.72M | 90.65M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 31.9M | 31.28M | -4.19M | -13.35M | -2.33M | -22.03M | -9.88M | 18.2M | 67.02M | 21.53M | 2.23M | 24.37M | 30.73M | 84.38M | 23.88M | 10.47M | 37.78M | 6.58M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -240K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 264K | 139K | n/a | -106K | 8K | n/a | 242K | 4.3M | 362K | 3K | 375K | n/a | 526K | 51K |
Financial Cash Flow | 120K | n/a | 239K | n/a | -116K | 119.88M | 242K | -105K | 8K | n/a | 242K | 4.3M | 362K | 3K | 375K | n/a | 517K | 1.5M |
Net Cash Flow | -6.74M | -11.49M | -32.2M | -34.47M | -22.29M | 74.61M | -30.37M | -5.82M | 43.78M | -879K | -16M | -7.44M | 2.22M | 55.46M | -1.56M | -15.33M | 4.38M | -14.22M |
Free Cash Flow | -38.89M | -42.99M | -28.31M | -21.34M | -19.86M | -23.34M | -21.6M | -24.41M | -23.29M | -22.5M | -18.66M | -32.63M | -35.31M | -33.3M | -30.17M | -31.52M | -37.56M | -23.71M |